Fitbit

By Mallory Hackett 11:44 am September 14, 2020
Fitbit’s new electrocardiogram app has officially received regulatory clearance in the U.S. and European Union for its latest smartwatch, the Fitbit Sense, to monitor heart rhythm and detect atrial fibrillation. Now that the app has 510(k) clearance from the U.S. Food and Drug Administration and CE marking, Fitbit Sense users can access the ECG app beginning in October. The company conducted a...
By Mallory Hackett 11:28 am August 25, 2020
Fitbit announced today three new wearables – the Fitbit Sense, Fitbit Versa 3 and Fitbit Inspire 2 – to its product pipeline. The Fitbit Sense marks the company’s first “advanced health” smartwatch, including an electrodermal activity (EDA) sensor, an electrocardiogram app, a heart rate tracker and an on-wrist skin temperature sensor with more than six days of battery life. It costs $329 and...
By Mallory Hackett 10:56 am August 19, 2020
Fitbit may be able to detect COVID-19 in patients before they start to feel symptoms, based on early findings from the company’s “Assessment of physiological signs associated with COVID-19 measured using wearable devices” preprint study. The study includes preliminary data that has yet to be peer reviewed by a medical journal. With the research gathered in its study, Fitbit hopes to create an...
By MobiHealthNews 02:38 pm August 7, 2020
Shortly before news broke that Teladoc was set to acquire Livongo, the chronic disease management company announced its quarterly earnings results. On Aug. 5 it announced that its second quarter total revenue came in at $91.9 million, which was up 125% YoY. The company reported a GAAP gross margin of 76.6% and non-GAAP gross margin of 77.3%. The company attributed the gains to its growing...
By Dave Muoio 11:52 am August 4, 2020
It's been about nine months since Google officially announced plans to acquire Fitbit. The deal was expected to close in Q2 2020, but antitrust concerns from U.S. and E.U. regulators have so far stalled the purchase. That delay will likely run a fair bit longer with the European Commission announcement that its preliminary probe of the purchase will now expand into a full-scale investigation...
By Dave Muoio 02:48 pm July 13, 2020
UnitedHealth Group announced plans this morning to distribute a device-driven diabetes management model to 230,000 employer-sponsored members with Type 2 diabetes at no additional cost. The pilot program, called Level2 by UnitedHealthcare, provides members with a Dexcom G6 continuous glucose monitor (CGM) that connects to their smartphone, a Fitbit activity tracker, personalized coaching and...
By Dave Muoio 09:33 am June 16, 2020
With much of the world gradually returning to work after COVID-19 lockdowns, Fitbit sees a new opportunity to engage its employer customers with device- and app-driven health monitoring. The company today announced what it's calling its Ready for Work solution, a service comprising a daily health check-in for employees and an analytics dashboard for their employers, both of which are being...
By Dave Muoio 02:21 pm May 22, 2020
Fitbit has launched an in-app study the company says could help develop an algorithm for detecting potential COVID-19 cases prior to symptom onset. Device owners over the age of 21 who live in the U.S. or Canada who either had a confirmed case of COVID-19 or recently experienced symptoms consistent with the disease are invited to take part in what the company has dubbed the Fitbit COVID-19 study...
By Laura Lovett 04:14 pm May 15, 2020
About a week after Fitbit released its disappointing Q1 financials, its CEO James Park announced to CNBC that the company is looking to the ventilator space, in a temporary effort to address the coronavirus pandemic.  The news, which was confirmed by sources at Fitbit, means major changes are in the works for the wearable company. Park told CNBC that the company will be submitting its new...
By MobiHealthNews 03:23 pm May 8, 2020
This quarter Dexcom raked in $405 million in revenue, compared to $280.5 million in 2019’s Q1. This represents a 44% increase year over year (YoY), and beats the company's revenue goal by $46.7 million. Dexcom attributes its success to its growing user rate. The gross profits from Q1 were $258.7 million. However, operating expenses have increased, coming in at $215.4 million in 2020 Q1, versus $...